Issue 27, 2025

BODIPY-coelenterazine conjugates as self-illuminating substrates for NanoLuc

Abstract

We report how the conjugation of coelenterazine (CTZ) to BODIPY retains its activity as a versatile substrate for luciferase-type enzymes opening the possibility of taking advantage of BODIPY's fluorescent properties and capacity to generate singlet oxygen. Bioluminescence imaging-guided photodynamic therapy or 1O2-triggered drug release are potential applications of these conjugates.

Graphical abstract: BODIPY-coelenterazine conjugates as self-illuminating substrates for NanoLuc

Supplementary files

Article information

Article type
Communication
Submitted
09 Nov 2024
Accepted
03 Mar 2025
First published
03 Mar 2025
This article is Open Access
Creative Commons BY license

Chem. Commun., 2025,61, 5190-5193

BODIPY-coelenterazine conjugates as self-illuminating substrates for NanoLuc

V. Viereckt, F. Abendroth, A. Schauerte, M. Gerhard, C. Lichtenberg, D. Kosenkov and O. Vázquez, Chem. Commun., 2025, 61, 5190 DOI: 10.1039/D4CC05979D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements